Archive for October, 2008

Survival Of Diabetic Mice Improved After Transplantation Of Human Embryonic Stem Cell Derived ILCs

Wednesday, October 29th, 2008
Geron Corporation (Nasdaq:GERN) today announced the publication of data showing the successful engraftment of human embryonic stem cell (hESC)-derived pancreatic islet-like clusters (ILCs) in diabetic mice. After transplantation, the ILCs continued to express important pancreatic islet proteins, responded to high levels of glucose in the blood, and extended the survival of recipient animals.

Storage Of Umbilical Cord Stem Cells Makes Sense - International Tissue Engineering Research Association

Tuesday, October 28th, 2008
Over 70 diseases can already be successfully treated with hematopoietic (blood) stem cells and around 15 diseases are treated with non-hematopoietic stem cells. Considering ongoing experiments and clinical trials, the number of therapeutic applications is expected to increase in the future. These are some of the results an expert panel presented after the first ITERA consensus meeting on the use, efficacy and medical applications of umbilical cord stem cells.

BioTime CEO Dr. Michael West Presents At GTCbio Advances In Stem Cell Discoveries Meeting “Embryomics: Implications For Regenerative Medicine”

Tuesday, October 28th, 2008
BioTime, Inc. (OTCBB:BTIM) Chief Executive Officer Michael West, Ph.D. will deliver a presentation this morning at the GTCbio Advances in Stem Cell Discoveries meeting in San Francisco. Dr.